Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022

To mitigate the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines have been rapidly developed and introduced in many countries. In Colombia, the population was vaccinated with four vaccines. Therefore, this research aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagón-Rojas, Jeadran, Mercado-Reyes, Marcela, Toloza-Pérez, Yesith G., Galindo, Marisol, Palma, Ruth M., Catama, Jenssy, Bedoya, Juan F., Parra-Barrera, Eliana L., Meneses, Ximena, Barbosa, Juliana, Tavera-Rodríguez, Pilar, Bermúdez-Forero, Andrea, Ospina-Martínez, Martha Lucía
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608587/
https://www.ncbi.nlm.nih.gov/pubmed/36298474
http://dx.doi.org/10.3390/vaccines10101609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608587/
https://www.ncbi.nlm.nih.gov/pubmed/36298474
http://dx.doi.org/10.3390/vaccines10101609

Ejemplares similares